Article
从筛选到验证：生物标志物诊断专利的公开与支持
Patent applications for biomarkers in disease diagnosis are rapidly growing, yet many fail to meet patent law requirements. While screening experiments can identify correlations between biomarkers and diseases, they alone cannot prove diagnostic value. This analysis examines why validation experiments demonstrating sensitivity and specificity are essential for patent approval, and how their absence leads to rejection under Chinese Patent Law Articles 26(3) and 26(4).
Kangxin